Fluctuations in plasma macrophage colony-stimulating factor levels during autologous peripheral blood stem cell transplantation for haematologic diseases

Clin Lab Haematol. 2002 Feb;24(1):37-42. doi: 10.1046/j.1365-2257.2002.00156.x.

Abstract

Plasma macrophage colony-stimulating factor (M-CSF) levels were measured in 13 haematologic patients treated with autologous peripheral blood stem cell transplantation (PBSCT). Six of the patients showed an increase in M-CSF peak levels (>3000 pg/ml) during the conditioning and stem cell infusion period. The peak levels of M-CSF in this phase correlated with thrombomodulin levels, indicating the endothelial origin of plasma M-CSF. However, the M-CSF levels were not influenced by TNFalpha. More patients with high M-CSF levels (>5000 pg/ml) suffered from organ failure than those with lower M-CSF levels. These results suggest that high M-CSF levels may correlate with cellular or organ damage in patients treated with PBSCT.

MeSH terms

  • Adult
  • Biomarkers / blood
  • Blood Cells / transplantation
  • Endothelium / metabolism
  • Endothelium / pathology
  • Hematologic Diseases / blood
  • Hematologic Diseases / complications
  • Hematologic Diseases / therapy*
  • Humans
  • Liver Failure / metabolism
  • Lymphoma, Non-Hodgkin / blood
  • Lymphoma, Non-Hodgkin / complications
  • Lymphoma, Non-Hodgkin / therapy
  • Macrophage Colony-Stimulating Factor / blood*
  • Middle Aged
  • Stem Cell Transplantation / adverse effects*
  • Thrombomodulin / blood
  • Transplantation Conditioning / methods
  • Transplantation, Autologous / adverse effects
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Biomarkers
  • Thrombomodulin
  • Tumor Necrosis Factor-alpha
  • Macrophage Colony-Stimulating Factor